Pular para o conteúdo
Albinismo oculocutâneo tipo 1
ORPHA:352731CID-10 · E70.3CID-11 · EC23.20DOENÇA RARA
Esta doença tem causa genética. Recomendamos procurar um médico geneticista para diagnóstico, exames genéticos e aconselhamento familiar.
Visão / ocularInício neonatalHerança AR
Também conhecida comoOCA1OCAOCA1-MPOCA1-TS
Sinônimos clínicos: OCA1

Albinismo oculocutâneo tipo 1 (OCA1) descreve um grupo de albinismos oculocutâneos (OCA) relacionados à tirosina, que inclui o OCA1A, OCA1B, albinismo oculocutâneo tipo 1 de pigmentação mínima (OCA1-MP) e albinismo oculocutâneo tipo 1 sensível à temperatura (OCA1-TS).

Em construçãohistóricoSugerir correção
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

💬
EM LINGUAGEM SIMPLES

O albinismo oculocutâneo tipo 1 (OCA1) é uma condição genética rara de herança autossômica recessiva ligada a alterações no gene TYR, responsável pela enzima tirosinase. Ele costuma se manifestar desde os primeiros meses com hipopigmentação da pele, cabelos e sobrancelhas brancas, além de redução da visão, nistagmo e forte sensibilidade à luz. A condição não tem um PCDT publicado no Ministério da Saúde nem tratamentos medicamentosos dispensados pelo SUS, sendo o suporte focado em reabilitação e cuidados oftalmológicos e de proteção da pele.

📋
Informacoes curadas por IA — podem conter imprecisoes

Albinismo oculocutâneo tipo 1 (OCA1) descreve um grupo de albinismos oculocutâneos (OCA) relacionados à tirosina, que inclui o OCA1A, OCA1B, albinismo oculocutâneo tipo 1 de pigmentação mínima (OCA1-MP) e albinismo oculocutâneo tipo 1 sensível à temperatura (OCA1-TS).

Publicações científicas
69 artigos
Último publicado: 2026 Mar 23

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-9 / 100 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
2.5
Worldwide
Início
Infancy
+ neonatal
🏥
SUS: Cobertura mínimaScore: 15%
6 procedimentos SIGTAPCID-10: E70.3
🇧🇷Dados SUS / DATASUS
EXAMES E PROCEDIMENTOS RELACIONADOS (6)
•
Dosagem de aminoácidos (erros inatos)
•
Dosagem de ácidos orgânicos na urina
•
Teste de triagem para erros inatos do metabolismo
•
Sequenciamento completo do exoma (WES)
•
Teste do pezinho (triagem neonatal)
•
Atendimento em reabilitação — doenças raras
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
15 sintomas
🧬
Pele e cabelo
14 sintomas

+ 12 sintomas em outras categorias

Características mais comuns

90%prev.
Morfologia anormal da vasculatura coroidal
Muito frequente (99-80%)
90%prev.
Íris azuis
Muito frequente (99-80%)
90%prev.
Acuidade visual reduzida
Muito frequente (99-80%)
90%prev.
Anormalidade dos potenciais visuais evocados
Muito frequente (99-80%)
90%prev.
Fotofobia
Muito frequente (99-80%)
90%prev.
Fotossensibilidade cutânea
Muito frequente (99-80%)
41sintomas
Muito frequente (15)
Frequente (4)
Ocasional (1)
Muito raro (2)
Sem dados (19)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 41 características clínicas mais associadas, ordenadas por frequência.

Morfologia anormal da vasculatura coroidalAbnormal morphology of the choroidal vasculature
Muito frequente (99-80%)90%
Íris azuisBlue irides
Muito frequente (99-80%)90%
Acuidade visual reduzidaReduced visual acuity
Muito frequente (99-80%)90%
Anormalidade dos potenciais visuais evocadosAbnormality of visual evoked potentials
Muito frequente (99-80%)90%
FotofobiaPhotophobia
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico69PubMed
Últimos 10 anos48publicações
Pico202510 papers
Linha do tempo
2026Hoje · 2026📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.

Curadoria gene-doença

fontes oficiais
TYR
TYR
TYRTyrosinaseDisease-causing germline mutation(s) inTolerante
VIAS BIOLÓGICAS (2)
Melanin biosynthesisRegulation of MITF-M-dependent genes involved in pigmentation
MECANISMO DE DOENÇA

Albinism, oculocutaneous, 1A

An autosomal recessive disorder in which the biosynthesis of melanin pigment is absent in skin, hair, and eyes. It is characterized by complete lack of tyrosinase activity due to production of an inactive enzyme. Patients present with a life-long absence of melanin pigment after birth, and manifest increased sensitivity to ultraviolet radiation with predisposition to skin cancer. Visual anomalies include decreased acuity, nystagmus, strabismus and photophobia.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Sun Exposed Lower leg
7.7 TPM
Skin Not Sun Exposed Suprapubic
6.6 TPM
Aorta
0.1 TPM
Testículo
0.1 TPM
Glândula salivar
0.1 TPM
OUTRAS DOENÇAS (5)
oculocutaneous albinism type 1Boculocutaneous albinism type 1Aminimal pigment oculocutaneous albinism type 1Waardenburg syndrome type 2
HGNC:12442UniProt:P14679

Variantes genéticas (ClinVar)

408 variantes patogênicas registradas no ClinVar.

🧬 TYR: NM_000372.5(TYR):c.158G>A (p.Gly53Asp) ()
🧬 TYR: NM_000372.5(TYR):c.308G>C (p.Cys103Ser) ()
🧬 TYR: NM_000372.5(TYR):c.411C>A (p.Tyr137Ter) ()
🧬 TYR: NM_000372.5(TYR):c.1147G>C (p.Asp383His) ()
🧬 TYR: NM_000372.5(TYR):c.866G>C (p.Cys289Ser) ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 33 variantes classificadas pelo ClinVar.

33
Patogênica (100.0%)
VARIANTES MAIS SIGNIFICATIVAS
TYR: NM_000372.5(TYR):c.265del (p.Cys89fs) [Pathogenic]
TYR: NM_000372.5(TYR):c.1169A>G (p.His390Arg) [Pathogenic/Likely pathogenic]
TYR: NM_000372.5(TYR):c.38del (p.Phe13fs) [Pathogenic]
TYR: NM_000372.5(TYR):c.1366+4629A>G [Likely pathogenic]
TYR: NM_000372.5:c.(1184+1_1185-1)_(1366+1_1367-1)del [Pathogenic]

Vias biológicas (Reactome)

2 vias biológicas associadas aos genes desta condição.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Albinismo oculocutâneo tipo 1

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
38 papers (10 anos)
#1

Insights from Computational Dynamic Active Site Mapping into Substrate Recognition and Mutation-Induced Dysfunction in Human Tyrosinase.

International journal of molecular sciences2026 Feb 18

The ability of enzymes to recognize and process structurally diverse substrates is fundamental to metabolic flexibility and biological regulation. In melanin biosynthesis, human tyrosinase (Tyr) catalyzes the oxidation of several chemically distinct intermediates, including L-tyrosine, L-DOPA, DHICA, and DHI. Although its catalytic chemistry is well established, the structural basis of substrate selectivity and how it is altered by disease-associated mutations remains unclear. Using molecular docking and molecular dynamics simulations, we mapped the Tyr active site and identified 23 evolutionarily conserved residues that mediate multi-substrate recognition and binding. Across all substrates, binding induces coordinated conformational responses, particularly within an anchoring region (334-347) that provides electrostatic and hydrophobic steering, and a flexible gating loop (374-386) that modulates access and stabilizes bound intermediates. The OCA1B-associated P406L mutation, although distant from the catalytic core, disrupts long-range dynamic coupling and impairs loop flexibility, while 25 ClinVar-listed genetic variants at substrate-interacting residues weaken active-site organization, underscoring the sensitivity of Tyr's dynamic network to perturbation. Integrating these findings, we propose an ordered multi-substrate binding mechanism in which substrates are first guided by the anchoring region, then aligned by the universal triad, and finally refined through loop-mediated, substrate-specific contacts. Our work suggests a dynamic framework that could be useful for understanding human tyrosinase catalysis, genetic mutation impact, and future engineering strategies.

#2

First Report of Oculocutaneous Albinism Type I Among Baka Pygmies From Cameroon.

Pigment cell &amp; melanoma research2026 Jan

Oculocutaneous albinism type 1 (OCA1) caused by pathogenic variants of the TYR gene is an autosomal recessive disorder of pigmentation characterized by reduced biosynthesis of melanin pigment in skin, hair, and eyes. We had the opportunity to examine five East Cameroon Baka rainforest hunter-gatherers (historically called "Pygmies") with albinism and belonging to three different families. Screening of known albinism genes revealed a homozygous missense variant in the TYR gene, NM_000372.5: c.1109T>C; p.Met370Thr. In addition, one patient was also hemizygous for a variant in GPR143, the gene involved in ocular albinism (OA1). Another patient was also heterozygous for the common African and Afro-American 2.7-kb deletion in the OCA2 gene indicating admixture of one parent with neighboring Nzimé Bantu-speaking farmers. This is the first report of the occurrence of OCA1 in African rainforest hunter-gatherers.

#3

Quantifying functional vision in a mouse model of oculocutaneous albinism type 1.

Scientific reports2026 Mar 23
#4

Alterations of Photoreceptor Synaptic Ribbons in the Retina of a Human Patient With Oculocutaneous Albinism Type 1 (OCA1).

Investigative ophthalmology &amp; visual science2025 Oct 01

Albino (Tyrc-2J/Tyrc-2J) C57BL/6J mice carry a mutation in the tyrosinase gene and are known to display alterations of photoreceptor synaptic ribbons. In the present study, we wanted to test whether similar alterations exist in oculocutaneous albinism type 1 (OCA1), a human disease that also results from mutations in the tyrosinase gene. In the present study, we assessed the morphology of a human OCA1 retina in comparison to control human retinas. We analyzed the retina of a 35-year-old OCA1 patient by immunolabeling at light and electron microscopic levels, conventional transmission electron microscopy, and by genomic DNA sequencing of the RIBEYE/CtBP2 gene in comparison to normal human controls. The morphological analyses revealed an overall surprisingly normal appearance of the retina, except for the presence of strikingly abnormal photoreceptor synaptic ribbons. Synaptic ribbons are presynaptic specializations of the continuously active retinal ribbon synapses and mainly consist of the RIBEYE protein. In the OCA1 patient, photoreceptor synaptic ribbons were very small and reduced to small fragments that were either still associated with the active zone transmitter release site or floating in the cytosol. The RIBEYE gene appeared to be unaltered in the OCA1 patient, except for some single nucleotide polymorphisms (SNPs) that were also present in controls. The OCA1 patients displayed similar defects of photoreceptor synaptic ribbons as previously observed in the albinotic mice with a defect in the tyrosinase gene. The observed alterations of synaptic ribbons are not due to mutations in the RIBEYE gene but are likely indirect consequences of the deficient melanin biosynthesis in the OCA1 patient.

#5

TYROSINASE-Deficient Human Retinal Pigment Epithelium Exhibits Melanosome Maturation Defects.

Investigative ophthalmology &amp; visual science2025 Oct 01

Oculocutaneous albinism type 1A (OCA1A) is a rare recessive genetic condition caused by mutations in TYROSINASE (TYR) that results in pigmentation defects of the skin, hair and eyes. This study was performed to understand melanosome biogenesis and maturation defects in an OCA1A in vitro model using retinal pigment epithelium (RPE) derived from TYR knockout human induced pluripotent stem cells (iPSC). CRISPR-Cas9 was used to knockout the TYR gene in iPSC to generate an isogenic pair. A developmentally guided protocol was used to differentiate the isogenic iPSC pair towards RPE monolayer tissue. Monolayer organization, melanosome formation and maturation were studied using electron microscopy. Loss of TYR protein was studied using Western blot and immuno-fluorescence staining. RPE cellular morphology and junction integrity was studied using immunofluorescence staining and transepithelial resistance measurements. An isogenic pair comprising of untargeted control and TYR knockout iPSC were successfully differentiated towards RPE monolayer tissue with polygonal cell morphology. TYR knockout RPE exhibited significantly reduced TYR protein, increased presence of immature pre-melanosomes and a complete lack of mature melanosomes. We observed abnormal junctional localization of β-catenin staining pattern, as has been reported previously for albino mouse RPE- and OCA1A patient-derived RPE. Differentiation of TYR-deficient iPSC toward RPE displayed pigmentation defects and absence of mature melanosomes, whereas melanosome biogenesis was not affected, because pre-melanosomes were still observed. These observations were also similar to what was observed in OCA1A patient-derived RPE monolayer tissue, independently confirming the validity of these previous findings.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC29 artigos no totalmostrando 48

2026

Quantifying functional vision in a mouse model of oculocutaneous albinism type 1.

Scientific reports
2026

Insights from Computational Dynamic Active Site Mapping into Substrate Recognition and Mutation-Induced Dysfunction in Human Tyrosinase.

International journal of molecular sciences
2026

First Report of Oculocutaneous Albinism Type I Among Baka Pygmies From Cameroon.

Pigment cell &amp; melanoma research
2025

Generation and ophthalmological characterization of oculocutaneous albinism type 1 pig models by selection-free genome editing.

Scientific reports
2025

Alterations of Photoreceptor Synaptic Ribbons in the Retina of a Human Patient With Oculocutaneous Albinism Type 1 (OCA1).

Investigative ophthalmology &amp; visual science
2025

TYROSINASE-Deficient Human Retinal Pigment Epithelium Exhibits Melanosome Maturation Defects.

Investigative ophthalmology &amp; visual science
2025

Rare phenotypes of white coat color in Simmental calves: genetic causes of syndromic forms of albinism and depigmentation.

Molecular genetics and genomics : MGG
2025

Genetic mutations disrupt the coordinated mode of tyrosinase's intra-melanosomal domain.

Protein science : a publication of the Protein Society
2025

Genetic mutations disrupt the coordinated mode of tyrosinase intra-melanosomal domain.

bioRxiv : the preprint server for biology
2025

Multiplexed Assays of Variant Effect and Reclassification of TYR Variants in Chinese Patients with Oculocutaneous Albinism.

The Journal of investigative dermatology
2025

Arcuate pattern of retinal ganglion cell axons in oculocutaneous albinism has implications for axon pathfinding.

BMJ case reports
2025

Human recombinant tyrosinase destabilization caused by the double mutation R217Q/R402Q.

Protein science : a publication of the Protein Society
2025

A 65 kilobase deletion of the upstream TYR gene region in a family with oculocutaneous albinism type 1.

Gene
2024

Albinism and Blood Cell Profile: The Peculiar Case of Asinara Donkeys.

Animals : an open access journal from MDPI
2024

Altered Functional Responses of the Retina in B6 Albino Tyrc/c Mice.

Investigative ophthalmology &amp; visual science
2024

After an initial Hermansky-Pudlak syndrome clinical diagnosis, molecular testing reveals variants for oculocutaneous albinism type 1B: A case report.

Molecular genetics &amp; genomic medicine
2024

Genotypic spectrum of albinism in Mali.

Pigment cell &amp; melanoma research
2024

Generation and characterization of retinal pigment epithelium from patient iPSC line to model oculocutaneous albinism (OCA)1A disease.

Journal of biosciences
2024

Visual acuity improvement in children with albinism beyond the first decade of life.

PloS one
2024

Reduction of lens size in PAX6-related aniridia.

Experimental eye research
2023

Evaluating the Cysteine-Rich and Catalytic Subdomains of Human Tyrosinase and OCA1-Related Mutants Using 1 μs Molecular Dynamics Simulation.

International journal of molecular sciences
2023

Identification and characterization of the compound heterozygous variants of TYR gene in a northern Chinese family with Oculocutaneous albinism type 1.

Pigment cell &amp; melanoma research
2022

NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.

BMC genomics
2022

Identification and characterization of two novel noncoding tyrosinase (TYR) gene variants leading to oculocutaneous albinism type 1.

The Journal of biological chemistry
2022

The Phenotypic and Mutational Spectrum of the FHONDA Syndrome and Oculocutaneous Albinism: Similarities and Differences.

Investigative ophthalmology &amp; visual science
2022

Evidence that the Ser192Tyr/Arg402Gln in cis Tyrosinase gene haplotype is a disease-causing allele in oculocutaneous albinism type 1B (OCA1B).

NPJ genomic medicine
2022

In vitro disease modeling of oculocutaneous albinism type 1 and 2 using human induced pluripotent stem cell-derived retinal pigment epithelium.

Stem cell reports
2021

Characterization of Temperature-Dependent Kinetics of Oculocutaneous Albinism-Causing Mutants of Tyrosinase.

International journal of molecular sciences
2021

Does Early Glasses Wear Improve Visual Outcome in OCA1A?

Journal of binocular vision and ocular motility
2020

Functional in silico analysis of human tyrosinase and OCA1 associated mutations.

Journal of analytical &amp; pharmaceutical research
2021

The structure and function of the mouse tyrosinase locus.

Pigment cell &amp; melanoma research
2020

A genome-wide scan study identifies a single nucleotide substitution in the tyrosinase gene associated with white coat colour in a red deer (Cervus elaphus) population.

BMC genetics
2019

Modeling human point mutation diseases in Xenopus tropicalis with a modified CRISPR/Cas9 system.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2019

Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the TYR gene.

The British journal of ophthalmology
2019

The Molecular Basis of Chemical Chaperone Therapy for Oculocutaneous Albinism Type 1A.

The Journal of investigative dermatology
2018

Membrane-associated human tyrosinase is an enzymatically active monomeric glycoprotein.

PloS one
2018

Nystagmus and Platinum Hair.

JAMA
2018

Dynamic analysis of human tyrosinase intra-melanosomal domain and mutant variants to further understand oculocutaneous albinism type 1.

Journal of analytical &amp; pharmaceutical research
2017

The consequences of deglycosylation of recombinant intra-melanosomal domain of human tyrosinase.

Biological chemistry
2017

Purification of Recombinant Human Tyrosinase from Insect Larvae Infected with the Baculovirus Vector.

Current protocols in protein science
2017

Identification and characterization of the tyrosinase gene (TYR) and its transcript variants (TYR_1 and TYR_2) in the crab-eating macaque (Macaca fascicularis).

Gene
2017

Computational analysis of histidine mutations on the structural stability of human tyrosinases leading to albinism insurgence.

Molecular bioSystems
2017

Progressive retinal degeneration in a girl with Knobloch syndrome who presented with signs of ocular albinism.

Documenta ophthalmologica. Advances in ophthalmology
2017

Identification of a missense mutation in the tyrosinase gene in a Chinese family with oculocutaneous albinism type 1.

Molecular medicine reports
2016

A cross-sectional examination of visual acuity by specific type of albinism.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2017

Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.

Pigment cell &amp; melanoma research
2016

Functional assessment of tyrosinase variants identified in individuals with albinism is essential for unequivocal determination of genotype-to-phenotype correlation.

The British journal of dermatology
2016

The albinism of the feral Asinara white donkeys (Equus asinus) is determined by a missense mutation in a highly conserved position of the tyrosinase (TYR) gene deduced protein.

Animal genetics

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Albinismo oculocutâneo tipo 1.

É de uma associação que acompanha esta doença? Fale com a gente →

Doença com base genética

Um médico geneticista pode ajudar no diagnóstico de Albinismo oculocutâneo tipo 1 e no aconselhamento genético da família.

Vai consultar um especialista? Confirme o registro dele no conselho.
Conselhos e sociedades

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Perguntas frequentes

O que as famílias mais perguntam sobre esta doença — cada resposta com a fonte de onde saiu

Respostas geradas por IA a partir das fontes citadas

Não há cura descrita para o albinismo oculocutâneo tipo 1 e não existem medicamentos específicos aprovados por agências como o FDA para eliminar a condição. O acompanhamento envolve reabilitação e intervenções para apoiar a função visual e proteger a pele.

Referências

Fontes citadas no texto, publicações do grafo e bases de dados usadas neste verbete

6 publicações do grafo RarasNet (PubMed) · 6 bases de dados. Títulos, periódicos e PMIDs vêm direto da fonte, sem intermediação de IA.

  1. ORPHA:352731
    Orphanet
  2. GARD:4037
    GARD (NIH)
  3. Q1401065
    Wikidata

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Citar este verbete

Raras. (s.d.). Albinismo oculocutâneo tipo 1. Em Raras — Enciclopédia de Doenças Raras do Brasil. https://raras.org/doenca/albinismo-oculocutaneo-tipo-1

Formato APA. Conteúdo sob CC BY 4.0 — reuso livre com atribuição.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Albinismo oculocutâneo tipo 1
Compêndio · Raras BR

Albinismo oculocutâneo tipo 1

ORPHA:352731 · MONDO:0018135
🇧🇷 Brasil SUS
SIGTAP
6 procedimentos
Geral
Prevalência
1-9 / 100 000
Herança
Autosomal recessive
CID-10
E70.3 · Albinismo
CID-11
Início
Infancy, Neonatal
Prevalência
2.5 (Worldwide)
MedGen
UMLS
C0268494
EuropePMC
Wikidata
Papers 10a

📋 Origem dos dados

Esta página agrega dados de fontes públicas e oficiais. Dados sobre cobertura no SUS (PCDT, CEAF) são verificados ativamente por agente proativo (ver badge no infobox). Demais dados têm atribuição de fonte + data da última sincronização — clique para abrir o original.

Doença rara (ontologia)
fonte: Orphanet
Identificador unificado
fonte: MONDO
Indexação biomédica
fonte: MeSH (NLM)
Dado público estruturado
fonte: Wikidata
Rara